Tirzepatide Microdosing Therapy
GLP-1 + GIP Dual Agonist Longevity Protocol
Microdosing Tirzepatide is an advanced longevity protocol leveraging dual incretin activity to optimize metabolic function, insulin sensitivity, and nutrient utilization. Unlike traditional weight-focused dosing, this approach emphasizes long-term metabolic resilience and healthy aging.
Tirzepatide acts on both GLP-1 and GIP receptors, providing a broader metabolic effect compared to GLP-1 alone. At low doses, it supports glucose regulation, energy balance, and hormonal signaling while minimizing excessive appetite suppression. This dual-pathway activity may offer enhanced benefits in metabolic flexibility, body composition quality, and cardiometabolic health, making it a powerful tool for individuals focused on performance and longevity optimization.
Benefits
Related Products
Get your medications in 3 simple steps
Take the health questionnaire
Take the health questionnaire
Take the health questionnaire
Coaching & human support
Frequently asked questions
How does it work?
Dual Hormone Activation: Activates GLP-1 and GIP receptors for enhanced metabolic signaling.
Advanced Glucose Control: Improves insulin response and nutrient partitioning.
Metabolic Flexibility: Supports efficient use of carbohydrates and fats for energy.
What should I expect?
- Smooth, sustained metabolic support.
- Subtle appetite regulation.
- Improved energy and recovery.
- Enhanced adherence to structured nutrition plans.
- Precision dosing tailored to individual response.
- Ongoing clinician monitoring.
What are the side effects and precautions?
Common (Usually Mild):
- Mild nausea.
- Occasional bloating.
- Reduced appetite.
- Less Common / Rare:
- Gallbladder issues.
- Pancreatitis.
- Dehydration.
Precautions:
- Avoid if history of medullary thyroid carcinoma (MTC) or MEN 2.
- Use caution when transitioning from higher doses.
- Maintain hydration and adequate nutrition.
- Review all medications with your clinician.